Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin (CTLA-4-Ig), Drug Exposure

Variable Name

rx_ctla-4-ig

Created

2021-11-26

Last Modified

Thumbnail Image

Files

1 Download↓
ctla4lgs.csv (25.96 KB)
↓

Tags

Level of Review

Data Model

Abstract

Concept set intended to identity patients with exposures to medications Abatacept and Belatacept.

Affiliation(s)

Children's Hospital of Philadelphia
Washington University in St. Louis

Funder(s)

Provenance

This concept set was developed for the Comparative Effectiveness of Treatments for Recurrent Focal Segmental Glomerulosclerosis (FSGS) in Pediatric Kidney Transplantation study.

Description

This concept set was generated by string searching for terms “abatacept” and “belatacept.”

Development Code

Vocabulary

Medication Classification Level




Clinical Subjects Headings

Preview Concept Set

ctla4lgs.csv (292 rows)

Interactive spreadsheet view available in browser

Data Source

Related Phenotype

Related Person

Related Study

Thumbnail Image
Comparative Effectiveness of Treatments for Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplantation
Affiliation:St. Louis Children's Hospital
Study to compare efficacy and outcomes of various therapies used for recurrent focal segmental glomerulosclerosis (FSGS).

Related Concept Set

Thumbnail Image
Abatacept, Drug Exposure
Created:2020-03-04Affiliation:Children's Hospital of Philadelphia
This concept set was intended to identify Abatacept exposures among pediatric nephrology cohorts such as Glomerular Disease or Membranoproliferative Glomerulonephritis (MPGN).

Related Code

Related Publications

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.

Cite this Concept Set

Goodwin Davies, A. (2021, November). Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin (CTLA-4-Ig), Drug Exposure. [Concept Set]. PEDSpace Knowledge Bank. https://doi.org/10.24373/pdsp-317